Amy Schacterle's most recent trade in Acumen Pharmaceuticals Inc was a trade of 126,900 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acumen Pharma Inc | Amy Schacterle | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 126,900 | 126,900 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharma Inc | Amy Schacterle | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 84,600 | 92,303 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Amy Schacterle | Chief Regulatory Officer | Sale of securities on an exchange or to another person at price $ 1.98 per share. | 07 Jan 2026 | 1,097 | 7,703 | - | 2.0 | 2,176 | Common Stock |
| Acumen Pharma Inc | Amy Schacterle | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 13,200 | 13,200 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharma Inc | Amy Schacterle | Chief Regulatory Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 8,800 | 8,800 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Amy Schacterle | Chief Regulatory Officer | 05 Nov 2024 | 340,000 | 340,000 | - | - | Employee Stock Option (right to buy) |